Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 5Completed 4Recruiting 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 124INDUSTRY 88NIH 6NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Inoperable œsophageal Cancer 1Advanced Solid Tumors 1

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × NETWORK × Nivolumab × Clear all
NCT03461952 2024-02-22

NIMBLe

Canadian Cancer Trials Group

Phase 2 Terminated
4 enrolled 4 charts
Other solid neoplasm

Advanced Solid Tumors

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
8 enrolled

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡